Editas Medicine pricing shares at $16 for year's first IPO: reports

Editas Medicine Inc. EDIT, +0.00% priced shares for its initial public offering at the low end of the range, according to media reports late Tuesday, for what will be 2016’s first IPO. Editas will price 5.9 million shares at $16 a share, at the low end of its $16 to $18 range, to raise $94.4 million. That give Editas a market valuation of $571 million, according to Reuters. Cambridge, Mass.-based Editas develops treatments for genetic-based diseases via editing gene sequences.

Most Recent Posts:

MGB GRAPHICS CILP Program 220927 0912 150 POWERPOINT 2

Are you an Innovator? Applications for MGB Commercialization and Inclusive Leadership Program now open

The MGB Commercialization and Inclusive Leadership Program (CILP) is a one-day in-person program on commercial application and…

Read More
whalen kimberly 003502672 high res

Finding a Safer Way to Draw Pediatric Blood Led This Nurse to Innovate

The Blood Shield Transfer device allows safe transfer of pediatric blood to microcontainers and blood gas syringes…

Read More
Blog MGB Implements DexCare image

Mass General Brigham Implements DexCare to Support Care Integration and Advance Digital Health

Collaboration demonstrates Mass General Brigham’s commitment to digital transformation and enhancing patient experience   SEATTLE, Oct. 31, 2022…

Read More